New hope for painful skin condition: five drugs under study
NCT ID NCT03827798
First seen Feb 06, 2026 · Last updated May 02, 2026 · Updated 11 times
Summary
This study tests five different experimental drugs in people with moderate to severe hidradenitis suppurativa, a painful skin condition that causes abscesses and tunnels under the skin. The goal is to see if these drugs can reduce the number of abscesses and inflamed bumps without increasing draining tunnels. About 248 participants took part, and the study is now complete but not yet reporting final results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Medical Research
Sandy Springs, Georgia, 30328, United States
-
Dawes Fretzin Clinical Rea Group
Indianapolis, Indiana, 46256, United States
-
Medical University of South Carolina MUSC
Charleston, South Carolina, 29425, United States
-
NorthShore University Health System
Evanston, Illinois, 60201, United States
-
Novartis Investigative Site
Graz, 8036, Austria
-
Novartis Investigative Site
Brussels, 1070, Belgium
-
Novartis Investigative Site
Prague, Prague 1, 11000, Czechia
-
Novartis Investigative Site
Copenhagen, 2400, Denmark
-
Novartis Investigative Site
Roskilde, 4000, Denmark
-
Novartis Investigative Site
Antony, 92160, France
-
Novartis Investigative Site
Lyon, 69003, France
-
Novartis Investigative Site
Marseille, 13885, France
-
Novartis Investigative Site
Nice, 06202, France
-
Novartis Investigative Site
Reims, 51100, France
-
Novartis Investigative Site
Rouen, 76031, France
-
Novartis Investigative Site
Bochum, 44791, Germany
-
Novartis Investigative Site
Frankfurt, 60590, Germany
-
Novartis Investigative Site
Hamburg, 20246, Germany
-
Novartis Investigative Site
Schwerin, 19055, Germany
-
Novartis Investigative Site
Pécs, Baranya, 7623, Hungary
-
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, 4032, Hungary
-
Novartis Investigative Site
Budapest, H-1083, Hungary
-
Novartis Investigative Site
Szeged, H 6725, Hungary
-
Novartis Investigative Site
Kopavogur, 201, Iceland
-
Novartis Investigative Site
Rotterdam, South Holland, 3015 GD, Netherlands
-
Novartis Investigative Site
Groningen, 9713 GZ, Netherlands
-
Novartis Investigative Site
Granada, Andalusia, 18014, Spain
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Manises, Valencia, 46940, Spain
-
Novartis Investigative Site
Barcelona, 08041, Spain
-
Novartis Investigative Site
Las Palmas GC, 35010, Spain
-
Novartis Investigative Site
Valencia, 46026, Spain
-
Olympian Clinical Research
Clearwater, Florida, 33609, United States
-
Park Avenue Dermatology PA
Orange Park, Florida, 32073, United States
-
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, 17033-0850, United States
-
University Of South Florida
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.